169 related articles for article (PubMed ID: 15706458)
1. Use of nonprohibited hallucinogenic plants: increasing relevance for public health? A case report and literature review on the consumption of Salvia divinorum (Diviner's Sage).
Bücheler R; Gleiter CH; Schwoerer P; Gaertner I
Pharmacopsychiatry; 2005 Jan; 38(1):1-5. PubMed ID: 15706458
[TBL] [Abstract][Full Text] [Related]
2. Salvia divinorum: from Mazatec medicinal and hallucinogenic plant to emerging recreational drug.
Zawilska JB; Wojcieszak J
Hum Psychopharmacol; 2013 Sep; 28(5):403-12. PubMed ID: 23794315
[TBL] [Abstract][Full Text] [Related]
3. Salvinorin A content in legal high products of Salvia divinorum sold in Mexico.
Hernández-Bello R; García-Rodríguez RV; García-Sosa K; Peña-Rodríguez LM; Vázquez-Hernández M; Ramos-Morales FR; Corcoran O; Sánchez-Medina A
Forensic Sci Int; 2015 Apr; 249():197-201. PubMed ID: 25710779
[TBL] [Abstract][Full Text] [Related]
4. Salvia divinorum and the unique diterpene hallucinogen, Salvinorin (divinorin) A.
Valdés LJ
J Psychoactive Drugs; 1994; 26(3):277-83. PubMed ID: 7844657
[TBL] [Abstract][Full Text] [Related]
5. From local to global-fifty years of research on Salvia divinorum.
Casselman I; Nock CJ; Wohlmuth H; Weatherby RP; Heinrich M
J Ethnopharmacol; 2014 Feb; 151(2):768-83. PubMed ID: 24315983
[TBL] [Abstract][Full Text] [Related]
6. Salvia divinorum use and phenomenology: results from an online survey.
Sumnall HR; Measham F; Brandt SD; Cole JC
J Psychopharmacol; 2011 Nov; 25(11):1496-507. PubMed ID: 20937616
[TBL] [Abstract][Full Text] [Related]
7. [Salvinorin A and related diterpenes--biological activity and potential therapeutic uses].
Piekielna J; Fichna J; Janecka A
Postepy Biochem; 2012; 58(4):485-91. PubMed ID: 23662442
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological activity of salvinorin A, the major component of Salvia divinorum.
Listos J; Merska A; Fidecka S
Pharmacol Rep; 2011; 63(6):1305-9. PubMed ID: 22358078
[TBL] [Abstract][Full Text] [Related]
9. Neo-clerodane diterpenes from the hallucinogenic sage Salvia divinorum.
Shirota O; Nagamatsu K; Sekita S
J Nat Prod; 2006 Dec; 69(12):1782-6. PubMed ID: 17190459
[TBL] [Abstract][Full Text] [Related]
10. Determination of salvinorins and divinatorins in Salvia divinorum leaves by liquid chromatography/multistage mass spectrometry.
Medana C; Massolino C; Pazzi M; Baiocchi C
Rapid Commun Mass Spectrom; 2006; 20(2):131-6. PubMed ID: 16331747
[TBL] [Abstract][Full Text] [Related]
11. Psychopharmacology of the hallucinogenic sage Salvia divinorum.
Prisinzano TE
Life Sci; 2005 Dec; 78(5):527-31. PubMed ID: 16213533
[TBL] [Abstract][Full Text] [Related]
12. Salvia divinorum: an hallucinogenic mint which might become a new recreational drug in Switzerland.
Giroud C; Felber F; Augsburger M; Horisberger B; Rivier L; Mangin P
Forensic Sci Int; 2000 Aug; 112(2-3):143-50. PubMed ID: 10940599
[TBL] [Abstract][Full Text] [Related]
13. Analytical investigation of legal high products containing Salvia divinorum traded in smartshops and internet.
Xavier Moreira F; Carvalho F; de Lourdes Bastos M; Guedes de Pinho P
Forensic Sci Int; 2014 Sep; 242():255-260. PubMed ID: 25093918
[TBL] [Abstract][Full Text] [Related]
14. Subjective effects of Salvia divinorum.
Dalgarno P
J Psychoactive Drugs; 2007 Jun; 39(2):143-9. PubMed ID: 17703708
[TBL] [Abstract][Full Text] [Related]
15. Salvinorin A, an active component of the hallucinogenic sage salvia divinorum is a highly efficacious kappa-opioid receptor agonist: structural and functional considerations.
Chavkin C; Sud S; Jin W; Stewart J; Zjawiony JK; Siebert DJ; Toth BA; Hufeisen SJ; Roth BL
J Pharmacol Exp Ther; 2004 Mar; 308(3):1197-203. PubMed ID: 14718611
[TBL] [Abstract][Full Text] [Related]
16. Legally high? Legal considerations of Salvia divinorum.
Griffin OH; Miller BL; Khey DN
J Psychoactive Drugs; 2008 Jun; 40(2):183-91. PubMed ID: 18720668
[TBL] [Abstract][Full Text] [Related]
17. Biosynthesis of the psychotropic plant diterpene salvinorin A: Discovery and characterization of the Salvia divinorum clerodienyl diphosphate synthase.
Pelot KA; Mitchell R; Kwon M; Hagelthorn LM; Wardman JF; Chiang A; Bohlmann J; Ro DK; Zerbe P
Plant J; 2017 Mar; 89(5):885-897. PubMed ID: 27865008
[TBL] [Abstract][Full Text] [Related]
18. The hallucinogenic herb Salvia divinorum and its active ingredient salvinorin A inhibit enteric cholinergic transmission in the guinea-pig ileum.
Capasso R; Borrelli F; Capasso F; Siebert DJ; Stewart DJ; Zjawiony JK; Izzo AA
Neurogastroenterol Motil; 2006 Jan; 18(1):69-75. PubMed ID: 16371085
[TBL] [Abstract][Full Text] [Related]
19. The hallucinogenic herb Salvia divinorum and its active ingredient salvinorin A reduce inflammation-induced hypermotility in mice.
Capasso R; Borrelli F; Zjawiony J; Kutrzeba L; Aviello G; Sarnelli G; Capasso F; Izzo AA
Neurogastroenterol Motil; 2008 Feb; 20(2):142-8. PubMed ID: 17931335
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the psychoactive terpenoid salvinorin A content in five Salvia divinorum herbal products.
Wolowich WR; Perkins AM; Cienki JJ
Pharmacotherapy; 2006 Sep; 26(9):1268-72. PubMed ID: 16945049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
